跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
ARIPIPRAZOLE SUN aripiprazole 300 mg powder and diluent for prolonged release suspension for injection vial kit
Approved
STANDARD
ARIPIPRAZOLE SUN aripiprazole 300 mg powder and diluent for prolonged release suspension for injection vial kit
Sun Pharma ANZ Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
f974e882b078a07c
Company
Sun Pharma ANZ Pty Ltd
Type
Standard
Approval Details
Approval Id
f974e882b078a07c
Product Name
ARIPIPRAZOLE SUN aripiprazole 300 mg powder and diluent for prolonged release suspension for injection vial kit
Artg Id
485482
Artg Name
ARIPIPRAZOLE SUN aripiprazole 300 mg powder and diluent for prolonged release suspension for injection vial kit
Sponsor
Sun Pharma ANZ Pty Ltd
Company Detail Path
/organization/sun-pharma-anz-pty-ltd
Artg Date
2025-11-05
Registration Type
Medicine
Therapeutic Good Type
Medicines
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
f974e882b078a07c
Type
Standard
Back to TGA Approvals
ARIPIPRAZOLE SUN aripiprazole 300 mg powder and diluent for prolonged release suspension for injection vial kit - TGA Drug Approval Details